Research Papers:

Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells

Vincenza Ciaramella, Carminia Maria Della Corte, Concetta Di Mauro, Stefano Tomassi, Salvatore Di Maro, Teresa Troiani, Erika Martinelli, Roberto Bianco, Sandro Cosconati, Riccardo Pierantoni, Rosaria Meccariello, Rosanna Chianese, Fortunato Ciardiello and Floriana Morgillo _

PDF  |  HTML  |  How to cite

Oncotarget. 2018; 9:19273-19282. https://doi.org/10.18632/oncotarget.25018

Metrics: PDF 2128 views  |   HTML 2185 views  |   ?  


Vincenza Ciaramella1, Carminia Maria Della Corte1, Concetta Di Mauro2, Stefano Tomassi3, Salvatore Di Maro3, Teresa Troiani1, Erika Martinelli1, Roberto Bianco2, Sandro Cosconati3, Riccardo Pierantoni4, Rosaria Meccariello5, Rosanna Chianese4, Fortunato Ciardiello1 and Floriana Morgillo1

1Oncologia Medica, Dipartimento di Internistica Clinica e Sperimentale “F. Magrassi”, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy

2Oncologia Medica, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli “Federico II”, Naples, Italy

3DISTABIF, Università degli Studi della Campania Luigi Vanvitelli, Caserta, Italy

4Dipartimento di Medicina Sperimentale sez ‘F. Bottazzi’, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy

5Dipartimento di Scienze Motorie e del Benessere, Università di Napoli Parthenope, Napoli, Italy

Correspondence to:

Floriana Morgillo, email: [email protected]

Keywords: mesothelioma; KiSS1; biomarker; metastasis; EMT

Received: February 03, 2018     Accepted: February 27, 2018     Published: April 10, 2018


Purpose: Kisspeptin signaling, via its receptors GPR54, could be an essential players in the inhibition of mesothelioma progression, invasion and metastasis formation. The loss of KiSS1 by tumor cells has been associated with a metastatic phenotype but the mechanistic insights of this process are still unknown.

Experimental design: The blockade of the metastatic process at early stage is a hot topic in cancer research. We studied the role of KiSS1 on proliferation, invasiveness, migration abilities of mesothelioma cell lines focusing on the effect on epithelial-to-mesenchymal transition (EMT).

Results: Treatment with the KiSS1 peptide or with a synthesis peptide with longer half-life, the FTM080, significantly inhibited cell proliferation, migration and invasion of mesothelioma cell lines; the same treatment reduced the activity of MMP-2 and MMP-9 determining consequently a marked reduction in the invasiveness of primary tumors and metastases. Thespecificexpression of EMT markers, as E-caderin, Vimentin, Slug and Snail, suggested the inhibition of EMT after treatment with KiSS1 as well as the preservation of epithelial components.

Conclusion: Our results support anti-proliferative effect of KiSS1 in cancer cells and suggest that targeting the KiSS1/GPR54 system may represent a novel therapeutic approach for mesothelioma.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25018